Development of a Gastric-Resistant Formulation of Omeprazole with Kollicoat MAE 30 DP and 100 P and Characterization by USP-Resistance-Test and ESR-Spectroscopy
K. Mäder, Martin-Luther-University, 06099 Halle, Germany
K. Bräunig, K. Kolter and K. Meyer, BASF-Aktiengesellschaft, Development Pharma Ingredients, 67056 Ludwigshafen, Germany
Coating formulation Dissolution test of omeprazole in pH change Dissolution test of omeprazole in pH change
Omeprazole as an acid-labile substance must be administered in a gastric-
Film-coated tablets without Na Film-coated tablets with 10 % Na
resistant formulation. Therefore, enteric coating materials such as methacrylic
Formulation I Formulation II 2HPO4 and subcoating 2HPO4-addition
acid-ethyl acrylate-copolymers like Kollicoat® MAE 30 DP and Kollicoat®
Proportion [%] Proportion [%] Resistance Test Dissolution Test Resistance Test Dissolution Test Polymer suspension
The objective of this study was to test the performance of these polymers
Kollicoat MAE 30 DP, 6.8 mg/cm², without subcoating
Kollicoat MAE 30 DP, 5.8 mg/cm², with subcoating
in different thicknesses, the influence of subcoating with Kollicoat® IR on
Kollicoat MAE 100 P, 6.6 mg/cm², without subcoating
this performance, and also the effect of a 10 % Na
Kollicoat MAE 100 P, 5.5 mg/cm², with subcoating
tablet core as buffering agent to prevent acid attack. Pigment suspension Materials
Tablet cores (table 1), polyvinyl alcohol-polyethylene glycol graft copolymer
® IR, BASF Aktiengesellschaft), methacrylic acid-ethyl acrylate-
copolymers (Kollicoat® MAE 30 DP and 100 P, BASF Aktiengesellschaft),
10 20 30 40 50 60 70 80 90 100 110 120 10 20 30 40 50 60 70 80 90
10 20 30 40 50 60 70 80 90 100 110 120 10 20 30 40 50 60 70 80 90
triethyl citrate (Merck KGaA), talc (Riedel-de Haen), titanium dioxide
(E171, Kronos), red iron oxide (Sicovit® Red 30, E172, BASF Aktiengesellschaft),
Process parameters
disodium hydrogen phosphate dihydrate (Merck KGaA). Tablet preparation
The dissolved ESR-probe was granulated on Ludipress® in the Diosna
ESR-Spectra after 2 h in 0.08 N HCl ESR-Spectra after 2 h in 0.08 N HCl
mixer V 50 for 5 min at stage 1, sieved using an 800 µm-sieve and dried
Film-coated tablets with and without Na2HPO4 Film-coated tablets with and without Na2HPO4
for 20 min at 35 °C in the fluid bed (Glatt GPC 1). All tablet ingredients
were blended in the Diosna mixer V 50 for 3 min and compressed on a
Polymer: Kollicoat MAE 30 DP Polymer: Kollicoat MAE 100 P
Kilian RL 15 rotary press at 10 kN compression force. Tablet formulations Omeprazole Omeprazole tablets ESR-Spectroscopy with Na2HPO4
ESR spectra were obtained using a 1 GHz Magnetech ESR spectrometer
were treated in 0.1N HCl at 37 °C for 1 h and 2 h, removed and investigated.
The coupling constant of the ESR-probe depends on the pH value2).
The distance between the first and the third line of the intergrated ESR
spectra was used to determine the coupling constants and the pH
No omeprazole was liberated within 2 h in 0.08 N HCl from tablets
without Na2HPO4 coated with at least 6 mg/cm² enteric polymer
Spectrum Tablet Coating Conclusions
A 15 % aqueous solution of Kollicoat® IR was used for subcoating to achieve
Tablets with Na2HPO4 and coated with Kollicoat® MAE 30 DP resp. 100 P
released up to 7 % resp. 10 % omeprazole. A subcoating of 1 mg/cm²
Kollicoat MAE 30 DP and 100 P are suitable as gastric-
reduced the release to 5 % (Figure 2). All formulations with 10 mg/cm² were
resistant coatings at ³ 6 mg/cm².
A standard coating formulation1) was prepared for gastric-resistant coating
(Kollicoat® MAE 30 DP, 100 P and pigments).
totally resistant in HCl. After buffering the solution to pH 6.8, all coated
tablets liberated > 85 % within 60 min. An addition of 10 % Na
The coating was performed in an Accela Cota 24" (Manesty) equipped with
2HPO4 to the tablet core improves the stability of omeprazole by buffering the penetrating protons but
a Schlick 930/7-1-S35 spray gun in 5-kg batches.
By means of ESR-spectroscopy2) the protons which penetrated the
weakens the enteric properties.
tablet core could be detected. The peak intensity of the spectra increases
USP-Resistance Test
with the mobility of the ESR-probe, which corresponds to a higher water
The ESR-spectroscopy can successfully be used for acid detection
permeability of the film. In 0.1 N HCl treated tablets containing Na
The tablets were tested in a USP-dissolution tester apparatus 2 at 100 rpm
in cores of aged or acid treated samples.
spectra showed remarkable additional signals, in opposition to dry and
using 0.08 N HCl and phosphate buffer pH 6.8. The liberated omeprazole
unbuffered treated cores. The water permeability of tablets with Na
was determined by means of UV-VIS (306 nm). The concentration of
increases due to a higher pH in the tablet core, which weakens the enteric
omeprazole was calculated according to a previously determined
coating (Figures 3 and 4). In all measured samples, tablets with Kollicoat®
MAE 30 DP-coating were more resistant. References
1) Generic Drug Formulations with Kollicoat MAE grades, BASF Aktiengesellschaft, July 1999
The pH in the tablet core after 2 h was determined to be < 4.5 without
2) A. Brunner, K. Mäder, A. Göpferich: pH and Osmotic Pressure Inside Biogradable Microspheres During Erosion;
Pharm. Research 16, (6), 847-853, (1999)
Resident Scholarship: Primary Care Internal Medicine Residency Program A. Awards: Poster of Distinction: Digestive Disease Week Meeting, San Diego CA, May 19-22, 2012: • Telaprevir-Interferon-Ribavirin Trio versus Interferon-Ribavirin Duo Therapy for Chronic Hepatitis C: A Sequential Analysis of Randomized Controlled Trials. Njei B, et al. Presidential Poster Award: American C
Vergütungsvereinbarung für ärztliche Leistungen zur Diagnostik und ambulanten Eradikationstherapie von Trägern mit dem Methicillin-resistenten Staphylcoccus aureus (MRSA) in der vertragsärztlichen Versorgung gemäß § 87 Abs. 2a SGB V mit Wirkung zum 01.04.2012 bis zum 31.03.2014 Allgemeine Fragen zu MRSA Was bedeutet "Eradikationstherapie"? Vollständige Eliminierung e